XNAS
CCLDO
Market cap85mUSD
Oct 08, Last price
27.44USD
1D
0.00%
1Q
0.00%
IPO
7.86%
Name
CareCloud Inc
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CareCloud, Inc., founded in 1999 and headquartered in Somerset, New Jersey, is a leading healthcare information technology firm. Primarily serving the United States market, the company provides a comprehensive array of cloud-based solutions and associated business services to medical providers and hospitals. It operates through two distinct segments: Healthcare IT and Practice Management. Its Software-as-a-Service (SaaS) platform encompasses essential functions such as revenue cycle management, electronic health records (EHR), practice administration, business intelligence, virtual care, and patient experience tools, complemented by various software utilities and support services for medical groups and larger health systems. These offerings are designed to assist a wide range of clinical professionals, including doctors, nurses, and physician assistants, who bill for their professional services. The company adopted its current name, CareCloud, Inc., in March 2021, previously being known as MTBC, Inc.
Key people
Crystal Williams
President · since 2025
Stephen Snyder
Chief Executive Officer · since 2026
Norman Roth
Interim Chief Financial Officer, Corporate Controller · since 2024
Mahmud Haq
Executive Chairman of the Board · since 2018
A. Hadi Chaudhry
Co-Chief Executive Officer, Director · since 2025
William Korn
Director · since 2023
Independent Director · since 2014
John Daly
Independent Director · since 2013
Cameron Munter
Independent Director · since 2013
Lawrence Sharnak
Independent Director · since 2020
Legal address
C/O The Company Corporation
2711 Centerville Road
Suite 400
Wilmington, DE 19808
US
2711 Centerville Road
Suite 400
Wilmington, DE 19808
US
Headquarters
7 Clyde Road
Somerset, NJ 08873
US
Somerset, NJ 08873
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||